Christopher Leclercq

Christopher Leclercq's AcademicInfluence.com Rankings

Medical

#2650

World Rank

#3081

Historical Rank

Cardiology

#250

World Rank

#256

Historical Rank

medical Degrees

Download Badge

Medical

Christopher Leclercq's Degrees

Doctorate Medicine University of Medicine, Taunggyi
PhD Cardiology University of Medicine, Taunggyi

Why Is Christopher Leclercq Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Christopher Leclercq's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). (2013) (2221)
Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. (2001) (2186)
Results of the Predictors of Response to CRT (PROSPECT) Trial (2008) (2026)
Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study. (2002) (998)
2018 ESC Guidelines for the diagnosis and management of syncope (2018) (942)
Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay (2001) (809)
2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). (2013) (721)
2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. (2019) (630)
Acute hemodynamic effects of biventricular DDD pacing in patients with end-stage heart failure. (1998) (555)
Retiming the failing heart: principles and current clinical status of cardiac resynchronization. (2002) (515)
Cardiac resynchronization therapy: Part 1--issues before device implantation. (2005) (505)
Comparative effects of permanent biventricular and right-univentricular pacing in heart failure patients with chronic atrial fibrillation. (2002) (497)
Systolic Improvement and Mechanical Resynchronization Does Not Require Electrical Synchrony in the Dilated Failing Heart With Left Bundle-Branch Block (2002) (487)
213 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy (2013) (484)
2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. (2021) (467)
Echocardiographic evaluation of cardiac resynchronization therapy: ready for routine clinical use? A critical appraisal. (2004) (421)
Permanent Left Ventricular Pacing With Transvenous Leads Inserted Into The Coronary Veins (1998) (354)
2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management. (2012) (335)
2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management. (2012) (322)
Cardiac Dyssynchrony Analysis Using Circumferential Versus Longitudinal Strain: Implications for Assessing Cardiac Resynchronization (2005) (303)
Electrocardiographic predictive factors of long-term clinical improvement with multisite biventricular pacing in advanced heart failure. (1999) (301)
Cardiac resynchronization therapy in advanced heart failure the multicenter InSync clinical study ☆ (2002) (296)
Regional Alterations in Protein Expression in the Dyssynchronous Failing Heart (2003) (278)
Predictors of response to cardiac resynchronization therapy (PROSPECT)--study design. (2005) (244)
Six year experience of transvenous left ventricular lead implantation for permanent biventricular pacing in patients with advanced heart failure: technical aspects (2001) (238)
Hemodynamic importance of preserving the normal sequence of ventricular activation in permanent cardiac pacing. (1995) (233)
Surface electrocardiogram to predict outcome in candidates for cardiac resynchronization therapy: a sub‐analysis of the CARE‐HF trial (2009) (221)
Optimal right ventricular pacing site in chronically implanted patients: a prospective randomized crossover comparison of apical and outflow tract pacing. (1999) (221)
Avoiding non-responders to cardiac resynchronization therapy: a practical guide (2016) (216)
Clinical and electrocardiographic predictors of a positive response to cardiac resynchronization therapy in advanced heart failure. (2005) (216)
A randomized comparison of triple-site versus dual-site ventricular stimulation in patients with congestive heart failure. (2008) (216)
Pacemaker lead infection: echocardiographic features, management, and outcome (1999) (212)
Cardiac resynchronization therapy: Part 2--issues during and after device implantation and unresolved questions. (2005) (210)
Evidence of Structural Remodeling in the Dyssynchronous Failing Heart (2005) (193)
A pilot experience with permanent biventricular pacing to treat advanced heart failure. (2000) (151)
Comparative effects of permanent biventricular pacing for refractory heart failure in patients with stable sinus rhythm or chronic atrial fibrillation. (2000) (150)
A Randomized Comparison of Permanent Septal Versus Apical Right Ventricular Pacing: Short‐Term Results (2006) (149)
2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. (2014) (147)
Upgrading from Single Chamber Right Ventricular to Biventricular Pacing in Permanently Paced Patients with Worsening Heart Failure: The RD‐CHF Study (2007) (143)
Cardiac resynchronization therapy in patients with atrial fibrillation: the CERTIFY study (Cardiac Resynchronization Therapy in Atrial Fibrillation Patients Multinational Registry). (2013) (142)
ESC Guidelines on cardiac pacing and cardiac resynchronization therapy (2013) (138)
ALternate Site Cardiac ResYNChronization (ALSYNC): a prospective and multicentre study of left ventricular endocardial pacing for cardiac resynchronization therapy. (2016) (135)
Long‐Term Effects of Biatrial Synchronous Pacing to Prevent Drug‐Refractory Atrial Tachyarrhythmia: A Nine‐Year Experience (2000) (132)
Ventricular resynchronization: current state of the art. (2004) (132)
High prevalence of iron deficiency in patients with acute decompensated heart failure (2014) (124)
Practical Instructions for the 2018 ESC Guidelines for the diagnosis and management of syncope (2018) (121)
Iron deficiency: an emerging therapeutic target in heart failure (2014) (113)
Valve replacement in patients with critical aortic stenosis and depressed left ventricular function: predictors of operative risk, left ventricular function recovery, and long term outcome (2005) (113)
Estimation of myocardial work from pressure–strain loops analysis: an experimental evaluation (2018) (112)
Paced Left Ventricular QRS Width and ECG Parameters Predict Outcomes After Cardiac Resynchronization Therapy: PROSPECT-ECG Substudy (2011) (111)
Atrial fibrillation in trauma patients requiring intensive care (2006) (105)
Aneurysms and pseudoaneurysms of saphenous vein coronary artery bypass grafts (1998) (103)
The left atrial appendage, a small, blind-ended structure: a review of its echocardiographic evaluation and its clinical role. (2005) (99)
Resolution of left bundle branch block-induced cardiomyopathy by cardiac resynchronization therapy. (2013) (98)
A randomized double-blind comparison of biventricular versus left ventricular stimulation for cardiac resynchronization therapy: the Biventricular versus Left Univentricular Pacing with ICD Back-up in Heart Failure Patients (B-LEFT HF) trial. (2010) (95)
Systolic time intervals as simple echocardiographic parameters of left ventricular systolic performance: correlation with ejection fraction and longitudinal two-dimensional strain. (2010) (92)
Causes-of-death analysis of patients with cardiac resynchronization therapy: an analysis of the CeRtiTuDe cohort study (2015) (92)
Role of myocardial constructive work in the identification of responders to CRT (2018) (90)
CRT Survey II: a European Society of Cardiology survey of cardiac resynchronisation therapy in 11 088 patients—who is doing what to whom and how? (2018) (90)
Real-time three-dimensional speckle tracking echocardiography: a novel technique to quantify global left ventricular mechanical dyssynchrony. (2011) (88)
[Permanent atrial resynchronization by synchronous bi-atrial pacing in the preventive treatment of atrial flutter associated with high degree interatrial block]. (1994) (86)
Value of Myocardial Work Estimation in the Prediction of Response to Cardiac Resynchronization Therapy. (2017) (83)
ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2—care pathways, treatment, and follow-up (2021) (77)
Cardiac resynchronisation therapy in chronic atrial fibrillation: impact on left atrial size and reversal to sinus rhythm (2005) (76)
Cardiac resynchronization therapy non-responder to responder conversion rate in the more response to cardiac resynchronization therapy with MultiPoint Pacing (MORE-CRT MPP) study: results from Phase I. (2019) (74)
Resumption of sinus rhythm in patients with heart failure and permanent atrial fibrillation undergoing cardiac resynchronization therapy: a longitudinal observational study. (2010) (74)
Optimized implementation of cardiac resynchronization therapy: a call for action for referral and optimization of care (2020) (72)
Improvement in acute contractility and hemodynamics with multipoint pacing via a left ventricular quadripolar pacing lead (2014) (71)
Benefits of Endocardial and Multisite Pacing Are Dependent on the Type of Left Ventricular Electric Activation Pattern and Presence of Ischemic Heart Disease: Insights from Electroanatomic Mapping (2012) (70)
Combined antiplatelet therapy with ticlopidine and aspirin. A simplified approach to intracoronary stent management. (1996) (70)
Isolated left main coronary artery stenosis: long term follow up in 106 patients after surgery (2002) (69)
New devices in heart failure: an European Heart Rhythm Association report: developed by the European Heart Rhythm Association; endorsed by the Heart Failure Association. (2014) (68)
Personalization of a cardiac electromechanical model using reduced order unscented Kalman filtering from regional volumes (2013) (68)
Validation of an echocardiographic multiparametric strategy to increase responders patients after cardiac resynchronization: a multicentre study. (2009) (67)
Characteristics and long-term outcome of non-immune isolated atrioventricular block diagnosed in utero or early childhood: a multicentre study. (2012) (67)
Assessment of longitudinal and radial ventricular dyssynchrony in ischemic and nonischemic chronic systolic heart failure: a two-dimensional echocardiographic speckle-tracking strain study. (2008) (67)
A review of multisite pacing to achieve cardiac resynchronization therapy. (2015) (64)
EHRA expert consensus statement and practical guide on optimal implantation technique for conventional pacemakers and implantable cardioverter-defibrillators: endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), and the Latin-American Heart Rhythm Society (LAHRS (2021) (61)
Identification and characterization of super-responders after cardiac resynchronization therapy. (2010) (61)
Homozygotes for a R869G mutation in the beta -myosin heavy chain gene have a severe form of familial hypertrophic cardiomyopathy. (2000) (60)
Comparison of right ventricular septal pacing and right ventricular apical pacing in patients receiving cardiac resynchronization therapy defibrillators: the SEPTAL CRT Study (2015) (59)
Comparison of right ventricular septal pacing and right ventricular apical pacing in patients receiving cardiac resynchronization therapy defibrillators: the SEPTAL CRT Study (2015) (59)
Acute effects of multisite left ventricular pacing on mechanical dyssynchrony in patients receiving cardiac resynchronization therapy. (2013) (56)
Primary Prevention Implantable Cardioverter Defibrillator (ICD) Therapy in Women—Data From a Multicenter French Registry (2016) (55)
Intensity and daily reliability of the six-minute walk test in moderate chronic heart failure patients. (2004) (54)
European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population (2020) (53)
Permanent Left Atrial Pacing with a Specifically Designed Coronary Sinus Lead (1997) (53)
Implantable cardioverter defibrillators and cardiac resynchronisation therapy (2011) (52)
Adding Defibrillation Therapy to Cardiac Resynchronization on the Basis of the Myocardial Substrate. (2017) (52)
Randomised comparison of coronary stenting with and without balloon predilatation in selected patients (2001) (51)
ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2—care pathways, treatment, and follow-up (2021) (49)
Expert consensus of the French Society of Geriatrics and Gerontology and the French Society of Cardiology on the management of atrial fibrillation in elderly people. (2013) (48)
Imaging predictors of response to cardiac resynchronization therapy: left ventricular work asymmetry by echocardiography and septal viability by cardiac magnetic resonance (2020) (47)
Effects of cardiac resynchronization therapy on disease progression in chronic heart failure. (2006) (47)
[2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy Developed by the Task Force on cardiac pacing and cardiac resynchronization therapy of the European Society of Cardiology (ESC) With the special contribution of the European Heart Rhythm Association (EHRA)]. (2022) (47)
Predictors and Clinical Impact of Late Ventricular Arrhythmias in Patients With Continuous-Flow Left Ventricular Assist Devices. (2018) (46)
Incidence of paroxysmal atrial tachycardias in patients treated with cardiac resynchronization therapy and continuously monitored by device diagnostics. (2010) (44)
Cardiorespiratory adaptations during the six-minute walk test in chronic heart failure patients (2004) (44)
Androgen deprivation therapy and cardiovascular risk: No meaningful difference between GnRH antagonist and agonists-a nationwide population-based cohort study based on 2010-2013 French Health Insurance data. (2017) (43)
European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1—epidemiology, pathophysiology, and diagnosis (2021) (42)
2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. (2021) (41)
Combined score using clinical, electrocardiographic, and echocardiographic parameters to predict left ventricular remodeling in patients having had cardiac resynchronization therapy six months earlier. (2014) (41)
Mitral regurgitation in dilated cardiomyopathy: value of both regional left ventricular contractility and dyssynchrony. (2009) (41)
Echocardiographic reference ranges for myocardial work in healthy subjects: A preliminary study (2019) (40)
Corrigendum to '2017 ESC/EACTS Guidelines for the management of valvular heart disease' [Eur J Cardiothorac Surg 2017;52:616-664]. (2017) (39)
Cardiac Resynchronization Therapy With a Quadripolar Electrode Lead Decreases Complications at 6 Months: Results of the MORE-CRT Randomized Trial. (2016) (37)
Common Phenotype in Patients With Mitral Valve Prolapse Who Experienced Sudden Cardiac Death. (2018) (37)
Peripartum cardiomyopathy in the era of cardiac magnetic resonance imaging: first results and perspectives. (2010) (35)
Reverse Electrical Remodeling by Cardiac Resynchronization Therapy: Prevalence and Clinical Impact (2012) (35)
Dual- vs. single-chamber defibrillators for primary prevention of sudden cardiac death: long-term follow-up of the Défibrillateur Automatique Implantable—Prévention Primaire registry (2017) (35)
Addition of a second LV pacing site in CRT nonresponders rationale and design of the multicenter randomized V(3) trial. (2010) (35)
Left ventricular endocardial or triventricular pacing to optimize cardiac resynchronization therapy in a chronic canine model of ischemic heart failure. (2012) (35)
Idiopathic/Iatrogenic Left Bundle Branch Block-Induced Reversible Left Ventricle Dysfunction: JACC State-of-the-Art Review. (2018) (35)
EHRA White Paper: knowledge gaps in arrhythmia management-status 2019. (2019) (34)
Effects of cardiac resynchronisation therapy in patients with heart failure having a narrow QRS Complex enrolled in PROSPECT (2010) (34)
Premature ventricular complexes: diagnostic and therapeutic considerations in clinical practice (2019) (33)
There is plenty of room for cardiac resynchronization therapy devices without back-up defibrillators in the electrical treatment of heart failure. (2005) (32)
Understanding the mechanisms amenable to CRT response: from pre-operative multimodal image data to patient-specific computational models (2013) (32)
754-1 Biatrial Synchronous Pacing: A New Therapeutic Approach to Prevent Refractory Atrial Tachyarrhythmias (1995) (32)
2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: Developed by the Task Force on cardiac pacing and cardiac resynchronization therapy of the European Society of Cardiology (ESC) With the special contribution of the European Heart Rhythm Association (EHRA). (2022) (31)
Diagnosis and treatment of iron deficiency in patients with heart failure: expert position paper from French cardiologists. (2014) (31)
Multimodal Registration and Data Fusion for Cardiac Resynchronization Therapy Optimization (2014) (29)
Effectiveness of Extracorporeal Life Support for Patients With Cardiogenic Shock Due To Intractable Arrhythmic Storm (2017) (29)
Risk factors and prognostic impact of left ventricular assist device-associated infections. (2019) (29)
Diagnostic accuracy of lung ultrasound for identification of elevated left ventricular filling pressure. (2019) (29)
Dynamic risk assessment to improve quality of care in patients with atrial fibrillation: the 7th AFNET/EHRA Consensus Conference. (2020) (29)
Rationale and design of the AdaptResponse trial: a prospective randomized study of cardiac resynchronization therapy with preferential adaptive left ventricular‐only pacing (2017) (29)
Positive Response to Cardiac Resynchronization Therapy Reduces Arrhythmic Events After Elective Generator Change in Patients with Primary Prevention CRT‐D (2014) (29)
Impact of early complications on outcomes in patients with implantable cardioverter-defibrillator for primary prevention. (2016) (28)
Atrial function is altered in lone paroxysmal atrial fibrillation in male endurance veteran athletes (2018) (28)
Effect of age on survival and causes of death after primary prevention implantable cardioverter-defibrillator implantation. (2015) (28)
Effects of cardiac resynchronization therapy on heart rate variability in patients with chronic systolic heart failure and intraventricular conduction delay. (2003) (28)
Very high rate programming in primary prevention patients with reduced ejection fraction implanted with a defibrillator: Results from a large multicenter controlled study. (2017) (27)
Impact of Cardiac Resynchronization Therapy on Left Ventricular Mechanics: Understanding the Response through a New Quantitative Approach Based on Longitudinal Strain Integrals. (2015) (27)
Effects of permanent dual-chamber pacing on mitral regurgitation in hypertrophic obstructive cardiomyopathy. (1999) (26)
Features and Predictors of Ascending Aortic Dilatation in Association With a Congenital Bicuspid Aortic Valve (2003) (26)
European experience with a first totally leadless cardiac resynchronization therapy pacemaker system (2020) (25)
Implantable cardioverter-defibrillator therapy among patients with non-ischaemic vs. ischaemic cardiomyopathy for primary prevention of sudden cardiac death (2017) (24)
Pre- and postoperative tricuspid regurgitation in patients with severe symptomatic aortic stenosis: importance of pre-operative tricuspid annulus diameter (2018) (24)
Acute effects of biventricular pacing on right ventricular function assessed by tissue Doppler imaging. (2007) (24)
Absolute survival after cardiac resynchronization therapy according to baseline QRS duration: a multinational 10-year experience: data from the Multicenter International CRT Study. (2014) (24)
Clinical impact of an additional left ventricular lead in cardiac resynchronization therapy nonresponders: The V3 trial. (2017) (24)
Cardiac resynchronisation therapy in heart failure: Current status (2006) (23)
Left atrial reverse remodeling and cardiac resynchronization therapy for chronic heart failure patients in sinus rhythm. (2009) (23)
Cardiac resynchronization therapy: a cost or an investment? (2011) (23)
Usefulness of red cell distribution width in association with biological parameters in an epidemiological survey of iron deficiency in children. (1990) (23)
How to use digital devices to detect and manage arrhythmias: an EHRA practical guide. (2022) (22)
Usefulness of a clinical risk score to predict the response to cardiac resynchronization therapy. (2018) (22)
Concordance Between Mechanical and Electrical Dyssynchrony in Heart Failure Patients: A Function of the Underlying Cardiomyopathy? (2007) (22)
Clinical significance of septal deformation patterns in heart failure patients receiving cardiac resynchronization therapy (2017) (22)
Echocardiographic right ventricular strain analysis in chronic heart failure. (2007) (22)
Endocardial acceleration (sonR) vs. ultrasound-derived time intervals in recipients of cardiac resynchronization therapy systems. (2011) (22)
Early Ventricular Arrhythmias After LVAD Implantation Is the Strongest Predictor of 30-Day Post-Operative Mortality. (2019) (21)
Safety, feasibility, and outcome results of cardiac resynchronization with triple-site ventricular stimulation compared to conventional cardiac resynchronization. (2016) (21)
Left atrial function, a new predictor of response to cardiac resynchronization therapy? (2015) (21)
Myocardial constructive work and cardiac mortality in resynchronization therapy candidates. (2019) (21)
Impact of right ventricular contractility on left ventricular dyssynchrony in patients with chronic systolic heart failure. (2011) (21)
1965 Upgrading from right-ventricular pacing to biventricular pacing in previously paced patients with advanced heart failure: a randomized controlled study (2003) (21)
Perioperative management of antithrombotic treatment during implantation or revision of cardiac implantable electronic devices: the European Snapshot Survey on Procedural Routines for Electronic Device Implantation (ESS-PREDI). (2016) (20)
Wearable cardioverter-defibrillator in patients with a transient risk of sudden cardiac death: the WEARIT-France cohort study (2020) (20)
Questions and Answers on Diagnosis and Management of Patients with Peripheral Arterial Diseases: A Companion Document of the 2017 ESC Guidelines for the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS). (2017) (20)
Prediction of Nonarrhythmic Mortality in Primary Prevention Implantable Cardioverter-Defibrillator Patients With Ischemic and Nonischemic Cardiomyopathy. (2015) (20)
Hemodynamic Improvement in Cardiac Resynchronization Does Not Require Improvement in Left Ventricular Rotation Mechanics: Three-Dimensional Tagged MRI Analysis (2010) (20)
Prognostic Usefulness of Myocardial Work in Patients With Heart Failure and Reduced Ejection Fraction Treated by Sacubitril/Valsartan. (2020) (20)
Rational and design of EuroCRT: an international observational study on multi-modality imaging and cardiac resynchronization therapy (2017) (19)
Corrigendum to “2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk” (Atherosclerosis (2019) 290 (140–205), (S0021915019314595), (10.1016/j.atherosclerosis.2019.08.014)) (2019) (19)
Very late effects of dual chamber pacing therapy for obstructive hypertrophic cardiomyopathy. (2013) (19)
Defining nonvalvular atrial fibrillation: A quest for clarification. (2016) (18)
Incidence, predictors and clinical impact of electrical storm in patients with left ventricular assist devices: new insights from the ASSIST-ICD study. (2019) (18)
Device complications with addition of defibrillation to cardiac resynchronisation therapy for primary prevention (2018) (17)
Clinical and angiographic results of stenting for long coronary arterial atherosclerotic lesions. (1998) (17)
Rationale and design of a randomized clinical trial to assess the safety and efficacy of multipoint pacing therapy: MOre REsponse on Cardiac Resynchronization Therapy with MultiPoint Pacing (MORE‐CRT MPP–PHASE II) (2019) (17)
European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population. (2020) (17)
Coronary subclavian steal syndrome after left internal mammary bypass in a patient with Takayasu's disease. (2002) (17)
The PROFID project (2020) (17)
Biventricular vs. left univentricular pacing in heart failure: rationale, design, and endpoints of the B-LEFT HF study. (2006) (17)
Long-term reverse remodeling by cardiac resynchronization therapy with MultiPoint Pacing: A feasibility study of noninvasive hemodynamics-guided device programming. (2018) (16)
Benefits of left ventricular endocardial pacing comparing failed implants and prior non-responders to conventional cardiac resynchronization therapy: A subanalysis from the ALSYNC study. (2018) (16)
Localization of Residual Conduction Gaps After Wide Antral Circumferential Ablation of Pulmonary Veins. (2019) (16)
Use of drugs with potential cardiac effect in the setting of SARS-CoV-2 infection (2020) (15)
[Expert consensus of the French society of geriatrics and gerontology and the French society of cardiology on the management of atrial fibrillation in elderly people]. (2013) (15)
Association of estimated plasma volume status with hemodynamic and echocardiographic parameters (2020) (14)
Left univentricular pacing for cardiac resynchronization therapy (2016) (14)
Cardiac electronic implantable devices after tricuspid valve surgery. (2018) (14)
Temporal Trends Over a Decade of Defibrillator Therapy for Primary Prevention in Community Practice (2017) (14)
Mechanical dyssynchrony in heart failure: Still a valid concept for optimizing treatment? (2017) (14)
Upgrading from right ventricular pacing to biventricular pacing in pacemaker patients with chronic heart failure (2007) (13)
Do we have reasons to be enthusiastic about pacing to treat advanced heart failure? (1999) (13)
Non-vitamin K antagonist oral anticoagulants and heart failure. (2016) (13)
Importance of Atrial Contraction in Hypertrophic Obstructive Cardiomyopathy: Implications for Pacing Therapy (1996) (13)
Physiological cardiac pacing: an individual objective (1994) (13)
Cardiac resynchronization therapy: clinical results and evolution of candidate selection (2007) (13)
Junctional Rhythm During Slow Pathway Radiofrequency Ablation in Patients with Atrioventricular Nodal Reentrant tachycardia: Beat‐to‐Beat Analysis and Its Prognostic Value in Relation to Electrophysiologic and Anatomic Parameters (2000) (13)
Suicide Attempts Among LVAD Recipients: Real-Life Data From the ASSIST-ICD Study. (2020) (13)
European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population (2020) (13)
Low value of simple echocardiographic indices of ventricular dyssynchrony in predicting the response to cardiac resynchronization therapy (2010) (13)
Collateral blood flow between left coronary artery bypass grafts and chronically occluded right coronary circulation in patients with triple vessel disease. Observations during complete revascularisation of beating hearts. (2007) (13)
Problems and troubleshooting in regular follow-up of patients with cardiac resynchronization therapy. (2009) (12)
European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1—epidemiology, pathophysiology, and diagnosis (2021) (12)
Left ventricle assist device: when and which patients should we refer? (2012) (12)
MSCT labelling for pre-operative planning in cardiac resynchronization therapy. (2005) (12)
Predictors for short-term progressive heart failure death in New York Heart Association II patients implanted with a cardioverter defibrillator--the EVADEF study. (2010) (12)
[Is isolated atrial fibrillation genetically determined? Apropos of a familial history]. (1996) (12)
Outcome of Primary Prevention Implantable Cardioverter Defibrillator Therapy According to New York Heart Association Functional Classification. (2016) (12)
Clinical role of d-sotalol and d,l-sotalol in supraventricular arrhythmias, including pre-excitation. (1993) (12)
Cardiac resynchronization therapy in combination with implantable cardioverter-defibrillator. (2009) (12)
European Heart Rhythm Association Summit report 2014. (2016) (11)
Electrical Storms in Patients With Implantable Cardioverter-Defibrillators for Primary Prevention. (2016) (11)
Why biventricular pacing might be of value in refractory heart failure? (2000) (11)
Data fusion of Left Ventricle Electro-Anatomical Mapping and Multislice Computerized Tomography (2009) (11)
Synchronization and Registration of Cine Magnetic Resonance and Dynamic Computed Tomography Images of the Heart (2016) (11)
Additional electrodes on the Quartet™ LV lead provide more programmable pacing options than bipolar and tripolar equivalents (2016) (11)
Segmentation 3D multi-objets d'images scanner cardiaques : une approche multi-agents 3D Multi-Object Segmentation of Cardiac MSCT Imaging by using a Multi- Agent Approach (2009) (11)
Impact of exercise-induced mitral regurgitation on hypertrophic cardiomyopathy outcomes. (2016) (11)
Predictors of post-operative cardiovascular events, focused on atrial fibrillation, after valve surgery for primary mitral regurgitation (2018) (11)
Subcutaneous Implantable Cardioverter-Defibrillator Lead Extraction: First Multicenter French Experience. (2020) (10)
Prophylactic implantable cardioverter-defibrillator in the very elderly. (2019) (10)
An entirely leadless cardiac resynchronization therapy. (2018) (10)
How to improve outcomes with cardiac resynchronisation therapy: importance of lead positioning (2012) (10)
Early diagnosis and better rhythm management to improve outcomes in patients with atrial fibrillation: the 8th AFNET/EHRA consensus conference (2022) (10)
The extravascular implantable cardioverter‐defibrillator: The pivotal study plan (2021) (9)
[Importance of atrioventricular synchrony in hypertrophic obstructive cardiomyopathy treated by cardiac pacing]. (1995) (9)
Predictors and prognostic impact of new left bundle branch block after surgical aortic valve replacement. (2017) (9)
Past, present and future of cardiac resynchronization. (2012) (9)
[Use of the six-minute walk test in cardiology]. (2005) (9)
New Multiparametric Analysis of Cardiac Dyssynchrony: Machine Learning and Prediction of Response to CRT. (2019) (9)
Cardiac resynchronization therapy: from treatment to prevention. (2011) (8)
Coronary Vein Extraction in MSCT Volumes Using Minimum Cost Path and Geometrical Moments (2013) (8)
Cardiac Resynchronization Therapy is an Important Advance in the Management of Congestive Heart Failure (2003) (8)
Heart transplantation in selected patients aged 60 years and older: a two-decade retrospective and multicentre analysis (2017) (8)
Wearables, telemedicine, and artificial intelligence in arrhythmias and heart failure: Proceedings of the European Society of Cardiology: Cardiovascular Round Table. (2022) (8)
Imaging in cardiac resynchronization therapy: what does the clinician need? (2008) (8)
Reverse mechanical remodeling by biventricular pacing in congestive heart failure: one-year results from patients in atrial fibrillation in the MUSTIC (MUltisite STimulation in Cardiomyopathy) study (2002) (8)
[Infections on permanent endocavitary pacemaker leads: value of transesophageal echocardiography]. (1995) (8)
First clinical evaluation of an atrial haemodynamic sensor lead for automatic optimization of cardiac resynchronization therapy (2015) (8)
The emergence of Staphylococcus aureus as the primary cause of cardiac device-related infective endocarditis (2021) (8)
Differences in clinical characteristics and reported quality of life of men and women undergoing cardiac resynchronization therapy (2020) (8)
Transvenous Lead Extraction in Patients with Cardiac Implantable Device: The Impact of Systemic and Local Infection on Clinical Outcomes—An ESC-EHRA ELECTRa (European Lead Extraction Controlled) Registry Substudy (2022) (7)
Mechanical dyssynchrony in CRT: still searching for the Holy Grail. (2014) (7)
New guidelines for cardiac resynchronisation therapy: simplicity or complexity for the doctor? (2007) (7)
Assessment of cardiac resynchronisation therapy in patients with wide QRS and non-specific intraventricular conduction delay: rationale and design of the multicentre randomised NICD-CRT study (2016) (7)
Prediction of response to cardiac resynchronization therapy using a multi-feature learning method (2020) (7)
Why We Have to Use Cardiac Resynchronization Therapy-Pacemaker More. (2017) (7)
Comparative effects of ventricular resynchronization therapy in heart failure patients with or without coronary artery disease. (2004) (7)
Classification of LV wall motion in cardiac MRI using kernel Dictionary Learning with a parametric approach (2015) (7)
Effectiveness of Deep Sedation for Patients With Intractable Electrical Storm Refractory to Antiarrhythmic Drugs. (2020) (7)
Right ventricular exercise contractile reserve and outcomes after early surgery for primary mitral regurgitation (2017) (7)
Corrigendum to "2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk" [Atherosclerosis 290 (2019) 140-205]. (2019) (7)
A Hybrid Tissue-Level Model of the Left Ventricle: Application to the Analysis of the Regional Cardiac Function in Heart Failure (2009) (6)
Impact of COVID-19 on the incidence of cardiac arrhythmias in implantable cardioverter defibrillator recipients followed by remote monitoring (2021) (6)
Defining patients at-risk of non-response to cardiac resynchronization therapy. Value of rest and exercise echocardiography. (2014) (6)
Cardiac resynchronization therapy and atrial fibrillation. Do we have a final answer? (2008) (6)
Alternative left ventricular pacing approaches for optimal cardiac resynchronization therapy. (2019) (6)
Multi-modal data fusion for Cardiac Resynchronization Therapy planning and assistance (2015) (6)
Characterization of atrial fibrillation in real-world patients: testing the 4S-AF scheme in the Spanish and French cohorts of the EORP-AF Long-Term General Registry. (2021) (6)
Current status of reimbursement practices for remote monitoring of cardiac implantable electrical devices across Europe (2022) (6)
Erratum to "2019 ESC/EAS guidelines for the management of dyslipidemias: Lipid modification to reduce cardiovascular risk" [Atherosclerosis 290 (2019) 140-205]. (2019) (6)
The challenging right inferior pulmonary vein: A systematic approach for successful cryoballoon ablation. (2019) (6)
Discriminative dictionary learning for local LV wall motion classification in cardiac MRI (2019) (6)
The rationale and design of the SMART CRT trial (2018) (6)
[Heart re-synchronization with biventricular stimulation: new treatment for refractory heart failure]. (2002) (6)
FOCUS ISSUE: CARDIAC RESYNCHRONIZATION THERAPY STATE-OF-THE-ART PAPERS Cardiac Resynchronization Therapy (2005) (5)
HIGH PREVALENCE OF IRON DEFICIENCY IN PATIENTS ADMITTED FOR ACUTE DECOMPENSATED HEART FAILURE: A FRENCH STUDY (CARDIOFER) (2014) (5)
Electrocardiographic correlates of mechanical dyssynchrony in recipients of cardiac resynchronization therapy devices. (2015) (5)
Analysis of endocardial acceleration during intraoperative optimization of cardiac resynchronization therapy (2013) (5)
Outcomes in Guideline-Based Versus Off-Guideline Primary Prevention Implantable Cardioverter-Defibrillator Recipients. (2017) (5)
P416Six-month biventricular crt response with a quadripolar crt system in the more response on cardiac resynchronization Therapy with multipoint pacing (MORE -CRT MPP) trial (2017) (5)
Early mortality after implantable cardioverter defibrillator: Incidence and associated factors. (2019) (5)
Leadless left ventricular endocardial pacing for CRT upgrades in previously failed and high-risk patients in comparison with coronary sinus CRT upgrades (2021) (5)
Left ventricular function after correction of mitral regurgitation: Impact of the clipping approach (2019) (5)
Prophylactic implantable cardioverter defibrillators for primary prevention: From implantation to heart transplantation. (2018) (5)
Transvenous low energy internal cardioversion for atrial fibrillation refractory to external cardioversion: do non-obese patients benefit? (2004) (5)
Results of the Predictors of Response to Cardiac Resynchronization Therapy (PROSPECT) Trial (2007) (5)
Determinants of left atrial volume index in patients with aortic stenosis: A multicentre pilot study. (2017) (5)
Pilot study using 3D–longitudinal strain computation in a multi-parametric approach for best selecting responders to cardiac resynchronization therapy (2017) (5)
Increased valvulo‐arterial impedance differently impacts left ventricular longitudinal, circumferential, and radial function in patients with aortic stenosis: A speckle tracking echocardiography study (2017) (5)
Combined antiplatelet therapy without anticoagulation after stent implantation; the Ticlopidine Aspirin Stent Evaluation (TASTE) study (1996) (5)
Subcutaneous implantable cardioverter defibrillator indication in prevention of sudden cardiac death in difficult clinical situations: A French expert position paper. (2020) (5)
[Myocardial infarction and massive biventricular thrombosis during thrombocytopenia induced by pentosan polysulfate and heparin]. (1990) (4)
Very late effects of dual chamber pacing therapy for obstructive, hypertrophic cardiomyopathy (2013) (4)
[Medium-term results of multisite biventricular stimulation in severe cardiac failure]. (2002) (4)
Cost-effectiveness of a risk-stratified approach to cardiac resynchronisation therapy defibrillators (high versus low) at the time of generator change (2017) (4)
A03-6 Upgrading from rv pacing to biventricular pacing in previously paced patients with advanced heart failure: A randomized controlled study (2003) (4)
Predicting Clinical and Echocardiographic Response After Cardiac Resynchronization Therapy With a Score Combining Clinical, Electrocardiographic, and Echocardiographic Parameters. (2017) (4)
Does defibrillation testing influence outcomes after CRT-D implantation? A cause-of-death analysis from the DAI-PP study. (2016) (4)
One year prognostic value of B‐lines in dyspnoeic patients (2021) (4)
Factors predicting Sprint Fidelis lead fracture: Results at 5 years from a French multicentre registry. (2015) (4)
Importance of systematic right ventricular assessment in cardiac resynchronization therapy candidates: a machine-learning approach. (2021) (4)
Pacemaker replacement in nonagenarians: Procedural safety and long-term follow-up. (2015) (4)
Effectiveness of a patient education programme in heart failure with preserved ejection fraction: Results from the ODIN cohort study using propensity score matching. (2018) (4)
Left atrial strain is a predictor of left ventricular systolic and diastolic reverse remodelling in CRT candidates. (2021) (4)
Electrophysiological Study-Guided Permanent Pacemaker Implantation In Patients With Conduction Disturbances Following Transcatheter Aortic Valve Implantation. (2021) (4)
Optimized implementation of cardiac resynchronization therapy: a call for action for referral and optimization of care. (2021) (4)
Cardiac function estimation using Multislice Computed Tomography: A comparison to speckle tracking imaging (2009) (4)
Cardiovascular Disease in the Elderly: Proceedings of the European Society of Cardiology-Cardiovascular Round Table. (2022) (4)
Prognostic impact of permanent pacemaker implantation following transcatheter aortic valve replacement. (2022) (4)
Assessment of electrical and mechanical function in the paced LBBB failing heart using tagged MRI and epicardial mapping (2002) (4)
Expanding Indications for Resynchronization Therapy (2012) (4)
Comparative effects of ventricular resynchronization therapy in patients with LV systolic dysfunction of idiopathic or ischemic origin (2002) (3)
Influence of conduction time intervals on symptoms and exercise tolerance in patients with heart failure with left ventricular systolic dysfunction (2005) (3)
Optimized Implementation of cardiac resynchronization therapy – a call for action for referral and optimization of care (2021) (3)
Abstract 2819: Identification and Characterization of Super-Responders to Cardiac Resynchronization Therapy: An Echocardiographic Study (2008) (3)
[Acute relapsing pericarditis induced by screw-in atrial pacing lead. Apropos of 3 cases]. (1996) (3)
Cardiac resynchronization for asymptomatic or mildly symptomatic heart failure: a bridge too far? (2008) (3)
European Society of Cardiology quality indicators for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death (2022) (3)
AB43-4: Identification of potential CRT responders in narrow QRS using simple echo dyssynchrony parameters: Preliminary results of the desire study (2006) (3)
Efficacy and Safety of an Extravascular Implantable Cardioverter-Defibrillator. (2022) (3)
Why We Have to Use Cardiac Resynchronization Therapy-Pacemaker More. (2015) (3)
Left ventricular wall thickness assessed by cardiac computed tomography and cardiac resynchronization therapy outcomes. (2019) (3)
Detection of fibrosis in late gadolinium enhancement cardiac MRI using kernel dictionary learning-based clustering (2015) (3)
Procedural safety and long‐term follow‐up after pacemaker implantation in nonagenarians (2015) (3)
Monday, 27 August 2012 (2012) (3)
[Value of an algorithm of automatic adaptation of the atrio-ventricular delay to the instantaneous atrial rate in cardiac stimulation]. (1992) (3)
Reimbursement practices for use of digital devices in atrial fibrillation and other arrhythmias: a European Heart Rhythm Association survey. (2022) (3)
MULTISITE LEFT VENTRICULAR PACING IMPROVES ACUTE MECHANICAL DYSSYNCHRONY IN HEART FAILURE PATIENTS (2012) (3)
Abilities of cardiac MSCT imaging to provide useful anatomical and functional information for Cardiac Resynchronization Therapy optimization (2010) (3)
Cardiac resynchronization therapy in atrial fibrillation patients: amultinational registry: the certify study (2013) (3)
Lead fixation mechanism impacts outcome of transvenous lead extraction: Data from the European Lead Extraction ConTRolled Registry. (2021) (3)
An improved spatial tracking algorithm applied to coronary veins into Cardiac Multi-Slice Computed Tomography volume (2008) (3)
Segmentation-free MRI to CT 3D registration for Cardiac Resynchronization Therapy optimization (2012) (3)
A novel method for localization and ablation of conduction gaps after wide antral circumferential ablation of pulmonary veins. (2017) (3)
A randomized comparison of triple site versus dual site ventricular stimulation in patients with congestive heart failure, in: J Am Coll Cardiol, 51 (2008), 1455, et al (2008) (3)
FRAGILE: FRench Attitude reGistry in case of ICD LEad replacement. (2020) (2)
[Androgen deprivation and cardiovascular risk in prostate cancer treatment]. (2012) (2)
Peri-infarct pacing to prevent left reverse remodelling: an unvalidated concept? (2016) (2)
[Future of implantable electrical cardiac devices]. (2014) (2)
Direct Coronary Stenting in Noncomplex and Noncalcified Lesions: Immediate and Mid‐term Results of a Prospective Registry (2000) (2)
Implantable Cardioverter- Defibrillator Interference After LVAD Implantation. (2020) (2)
Peritoneal migration of an epicardial pacemaker. (2017) (2)
Management of patients with heart failure and secondary mitral regurgitation (2020) (2)
Left ventricular strain for predicting the response to cardiac resynchronization therapy: two methods for one question. (2021) (2)
Selection of patients responding to cardiac resynchronisation therapy: implications for echocardiography. (2009) (2)
Cryoballoon ablation of atrial fibrillation in patients with atypical right pulmonary vein anatomy. (2020) (2)
Cancer on a pacemaker lead. (2011) (2)
Computed Tomography-Guided Assessment of Response to Cardiac Resynchronization Therapy. (2019) (2)
Outcome of Temporary Circulatory Support As a Bridge-to-Left Ventricular Assist Device Strategy in Cardiogenic Shock Patients (2021) (2)
New hopes in the echocardiography of cardiac resynchronization therapy? Merits of a combined assessment of left ventricular dyssynchrony and contractility. (2010) (2)
Importance of concordance between left ventricular pacing sites and latest activated regions: myth or reality? (2007) (2)
AB48-3: Triple site ventricular pacing for optimizing ventricular resynchronization: Design of the TRIP-HF study; technical feasibility (2006) (2)
Implantable cardiac defibrillator leads dysfunction after LVAD implantation (2020) (2)
Importance of systematic right ventricular assessment in patients undergoing cardiac resynchronisation therapy: A machine-learning approach (2021) (2)
[Epidemiology and etiology of atrial fibrillation]. (2002) (2)
Exploring a New Systematic Route for Left Ventricular Pacing in Cardiac Resynchronization Therapy. (2021) (2)
Data fusion of left ventricle Electro-Anatomic Mapping and Multislice Computerized Tomography for Cardiac Resynchronisation Therapy optimization (2009) (2)
Cardiac function estimation for resynchronization therapy: Comparison between multislice-ct and speckle tracking imaging (2008) (2)
Cardiac Resynchronization Therapy in Patients With Atrial Fibrillation (2)
Prediction of the response to cardiac resynchronization therapy: is it worthwhile doing an echocardiography and looking for mechanical dyssynchrony? (2011) (2)
Multimodal Image Fusion for Cardiac Resynchronization Therapy Planning (2018) (2)
Upgrade to biventricular pacing in advanced heart failure patients previously implanted with a conventional pacemaker for a classical indication: is it worth it? (2002) (2)
Atrial Fibrillation in a Dual‐Chamber ICD Recipient with Activation of the Ventricular Intrinsic Preference Algorithm: What Is the Mechanism? (2016) (2)
Wearable cardioverter-defibrillator to reduce the transient risk of sudden cardiac death in coronary artery disease. (2020) (2)
[Patient information and coronary angiography: experience of the Rennes group]. (2001) (2)
Percutaneous Transluminal Coronary Angioplasty Using 6 Fr Guiding Catheters: A Matched Study with 8 Fr Guiding Catheters (1996) (1)
EHRA certification: a 15-year journey of attesting excellence in arrhythmia healthcare. (2021) (1)
Coronary lesions after DC ablation of accessory pathways: Preliminary results of a prospective study (1991) (1)
Machine learning-derived major adverse event prediction of patients undergoing transvenous lead extraction: Using the ESC EHRA EORP European lead extraction ConTRolled ELECTRa registry. (2022) (1)
Spatio-temporal registration of electro-anatomical mappings with functional data for CRT optimization (2012) (1)
CRT-Pacemaker Versus CRT-Defibrillator Who Needs Sudden Cardiac Death Protection? (2020) (1)
Prognostic utility of the assessment of diastolic function in patients undergoing cardiac resynchronization therapy. (2021) (1)
Left ventricular strain variations in cardiac surgery; The role of the type of surgery (2019) (1)
[Diagnostic and therapeutic strategy in coronary insufficiency in the elderly. Apropos of 65 cases]. (1993) (1)
Sudden cardiac death while waiting: do we need the wearable cardioverter-defibrillator? (2022) (1)
PO05-46: Novel insights into activation pattern along a quadripolar left ventricular lead in cardiac resynchronization therapy patients: Effect of right ventricular pacing vs. normal sinus rhythm (2016) (1)
[Loss of a stent in the left main coronary artery and secondary migration into the left circumflex artery needing surgical extraction. Apropos of a case]. (1996) (1)
Cardiac resynchronization therapy: which device to implant? (2008) (1)
Abstract 4850: Cardiac Resynchronisation Therapy in Elderly Patients: Outcome Data. A Secondary Analysis of CARE-HF (2008) (1)
[Use of propofol in 1350 anesthetized patients for electroconvulsive therapy]. (1991) (1)
Ventricular activation patterns during intrinsic conduction and right ventricular pacing in cardiac resynchronization therapy patients (2021) (1)
Upgrading from ventricular to physiological pacing: is it worth it? (2002) (1)
Acute Hemodynamic Benefits of Multisite Left Ventricular Pacing in Crt Recipients (2012) (1)
A Dream Came True (2012) (1)
P5-100: Long term effects of cardiac resynchronization therapy on atrial and ventricular remodeling in advanced heart failure patients with permanent atrial fibrillation and atrioventricular node ablation (2006) (1)
176-65: Long-term reverse remodeling of cardiac resynchronization therapy with MultiPoint Pacing using noninvasive hemodynamics-guided programming (2016) (1)
Utility of Computed Tomography to Predict Ventricular Arrhythmias in Patients With Nonischemic Cardiomyopathy Receiving Cardiac Resynchronization Therapy. (2019) (1)
Cardiac-resynchronization therapy. (2008) (1)
[Radiofrequency catheter ablation of accessory atrioventricular pathways: initial experience in 33 patients]. (1993) (1)
Myocardial constructive work is additive to volumetric response to CRT in the prediction of cardiac mortality after CRT implantation (2019) (1)
Implantable cardioverter defibrillator therapy for primary prevention of sudden cardiac death in the real world: Main findings from the French multicentre DAI-PP programme (pilot phase). (2019) (1)
Distance between the descending aorta and the left inferior pulmonary vein as a determinant of biophysical parameters during paroxysmal atrial fibrillation cryoablation (2021) (1)
[Tamponade due to Porphyromonas gingivalis]. (2006) (1)
P4-101: Crossover randomized comparison of chronic triple-site versus standard dual-site biventricular pacing in advanced heart failure: The TRIP-HF study (2006) (1)
P1140Influence of Etiology, QRS duration, and Baseline Systolic Function on Long-term CRT Response Rate with Multipoint Pacing: A Multicenter Experience (2018) (1)
Multisite Biventricular Pacing to Treat Refractory Heart Failure: Why and How? (2000) (1)
Perioperative LV strain (AVGGLS) alteration and predictive value for long term occurence of MACE (2019) (1)
Septuagenarian population has similar survival and outcomes to younger patients after left ventricular assist device implantation. (2020) (1)
0401: Left ventricular mechanics: novel tools to evaluate function and dyssynchrony in controls and cardiac resynchronization therapy candidates (2016) (1)
Management of aortic valve replacement according to the gradient across symptomatic aortic valve stenosis and its prognostic impact (2019) (1)
Twiddler's syndrome with a baroreflex stimulator device. (2016) (1)
[Magnetic resonance imaging in patients with pacemakers and implantable cardioverter-defibrillators: a systematic review]. (2010) (1)
[Role of cardiac resynchronisation in the treatment of cardiac failure]. (2004) (1)
Clinical predictors of challenging atrioventricular node ablation procedure for rate control in patients with atrial fibrillation. (2017) (1)
Left ventricular function after correction of a proportionate mitral regurgitation: Impact of the clipping approach (2020) (0)
I had a dream… (2018) (0)
P893Myocardial constructive work is additive to left ventricular dyssynchrony and volumetric response to CRT in the prediction of overall mortality after CRT implantation (2018) (0)
202: Atrio-ventricular electromechanical correlates in systolic heart failure with wide QRS (2013) (0)
[Cardiac resynchronisation therapy: what kind of equipment to use?]. (2005) (0)
[The esophageal approach in rhythmology]. (1995) (0)
Abstracts: Cardio resynchronisation therapy - Outcomes (2009) (0)
Radiation protection for healthcare professionals working in catheterisation laboratories during pregnancy: an EAPCI position statement in collaboration with EHRA, EACVI, the ESC Regulatory Affairs Committee and Women as One. (2022) (0)
P449Vectorcardiography illustrates enhanced electrical synchronization by multiPoint pacing (2017) (0)
[Impact of the aetiology of cardiac failure on the correlations between electrical and mechanical asynchrony of the ventricle]. (2006) (0)
Oral Abstract session: New insights in ventricular function: Friday 5 December 2014, 14:00-15:30 * Location: Agora (2014) (0)
The European Cardiac Arrhythmia Genetics (ECGen) Focus Group. (2021) (0)
Ventricular Resynchronization Therapy in Heart Failure Patients with Chronic Atrial Fibrillation: Is It Worthwhile ? (2002) (0)
081 Results of the survey ithaque: monitoring and therapies for systolic heart failure (2011) (0)
CLINICAL RELEVANCE WITH THE QUARTETw LEFT VENTRICULAR QUADRIPOLAR LEAD: QUARTO II STUDY (2017) (0)
P5684Left ventricular wall thickness measured with computed tomography stratifies the response to cardiac resynchronization therapy in patients with non-ischemic cardiomyopathy (2019) (0)
Long-term results of DDD pacing in hypertrophic obstructive cardiomyopathy Does pacing therapy influence survival? (2001) (0)
Triventricular Pacing: A Nice Concept to Be Proven. (2016) (0)
Poster session Friday 13 December - AM: 13/12/2013, 08:30-12:30 * Location: Poster area (2013) (0)
1072-209 PR interval prolongation but not QRS widening is an independent factor of functional intolerance in heart failure patients with dilated cardiomyopathy (2004) (0)
How to Program CRT Devices (2008) (0)
Changes in Plaque Composition and the Pleiotropic Effects of€Statins (0)
Myocardial constructive work is a predictor of long-term outcomes in patients with heart failure undergoing cardiac resynchronization therapy (2019) (0)
171: Risk scores versus pragmatic clinical assessment to predict operative risk in aortic valve replacement for aortic stenosis (2013) (0)
136-63: Performance of straight and spiral multipolar coronary sinus leads : preliminary results of the RALLY-X4 study (2016) (0)
125 Left Ventricular Systolic Mechanics is not the only determinant of response to Cardiac resynchronization Therapy (2010) (0)
0344 : Pacemaker replacement in nonagenarians: procedural safety and long-term follow-up (2015) (0)
Percutaneous mitral valve repair in secondary mitral regurgitation improves cardiac work (2018) (0)
State-of-the-Art of Left Ventricular Assist Device use in France: the ASSIST-ICD registry (2017) (0)
Success and complication rate of Tightrail mechanical percutaneous lead extraction: A multicentre French study (2021) (0)
Cardiac resynchronization therapy : which device to implant ? Resynchronisation cardiaque : quelle prothèse implanter ? (2008) (0)
DL-based classification of LV wall motion in cardiac MRI with a parametric approach (2015) (0)
Abstract 12605: Derivation and External Validation of a Cardiac Resynchronization Therapy Response Score (2015) (0)
Abstract 2650: Do Changes In Surface Ekg Predict The Clinical Response To Cardiac Resynchronisation Therapy: Data From The Care-hf Study (2007) (0)
109 Left ventricular systolic function and Response to Cardiac Resynchronization Therapy is influenced by Right ventricular function as assessed by Echocardiography (2010) (0)
557 Left ventricular diastolic function is a predictor of volumetric response to cardiac resynchronization therapy (2020) (0)
Radiofrequency ablation of right ventricular tachycardia in patients with no femoral access: safety and efficacy of a superior approach. (2019) (0)
457 Influence of heart failure aetiology on the relevance of QRS duration to predict the mechanical interventricular and left ventricular dyssynchrony (2005) (0)
His bundle pacing for correcting atrioventricular dyssynchrony in heart failure: HYPE or HOPE? (2023) (0)
FOCUS ISSUE: CARDIAC RESYNCHRONIZATION THERAPY There Is Plenty of Room for Cardiac Resynchronization Therapy Devices Without Back-Up Defibrillators in the Electrical Treatment of Heart Failure (2005) (0)
Long-Term Persistence of Diastolic Dysfunction and Dyspnea in Patients who Underwent Aortic Valve Replacement for Aortic Valve Stenosis (2019) (0)
Better diastolic function in CRT candidates is associated with improved survival after CRT implantation (2020) (0)
176-71: Insights into electrical delay between right and left ventricular leads in cardiac resynchronization therapy patients: effect of right ventricular pacing vs. normal sinus rhythm (2016) (0)
Prognostic role of myocardial work in patients with heart failure and reduced ejection fraction treated by sacubitril/valsartan (2020) (0)
219-05: ICD-related complications in patients with end-stage heart failure and left ventricular assist devices (2016) (0)
Left Ventricle Motion Estimation in Computed Tomography Imaging (2015) (0)
[Complications of myocardial infarction. Diagnosis, development, treatment]. (1995) (0)
Economic implications of adding a novel algorithm to optimize cardiac resynchronization therapy: rationale and design of economic analysis for the AdaptResponse trial (2020) (0)
2404The use of wearable cardioverter defibrillator in France (2019) (0)
194 Cardiac device-related infective endocarditis: microbiological specificities and prognostic factors (2010) (0)
164 Echocardiographic evaluation at rest and exercise capacity in systolic heart failure (2008) (0)
Relation of Body Mass Index to Outcomes in Patients With Heart Failure Implanted With Left Ventricular Assist Devices. (2020) (0)
Detection of Fibrosis in LGE-Cardiac MRI using Kernel DL-based Clustering (2015) (0)
PM033 Benefits of the Additional Electrodes in Quadripolar Left Ventricular Leads in Providing More Programmable Pacing Options for CRT Programming (2014) (0)
1074Predictors and clinical impact of late ventricular arrhythmias in patients with continuous-flow left ventricular assist devices (2018) (0)
A validation of the 4S-AF scheme in Spanish and French patients from the EORP-AF Long-Term General Registry (2021) (0)
The saga of dyssynchrony imaging: Are we getting to the point (2023) (0)
EDITORIAL Cardiac resynchronization therapy (2008) (0)
561 Targeting septal work and viability identifies responders to cardiac resynchronization therapy (2020) (0)
Hormonothérapie et risque cardiaque dans le traitement des cancers prostatiques Androgen deprivation and cardiovascular risk in prostate cancer treatment (2012) (0)
Leadless pacemaker implant in patients requiring CIED extraction: outcomes based upon timing of extraction (2021) (0)
[Accessory pathways of decremential conduction (Mahaim fibers). Treatment by endocavitary ablation; apropos of 8 cases]. (1997) (0)
Poster Session 2The imaging examination and quality assessment. (2016) (0)
AB39-4: Correlation between QRS-duration and mechanical dyssynchrony in non-ischemic cardiomyopathy differs from the ischemic ones : A 2D-strain study (2006) (0)
Do novel noninvasive ECG techniques improve patient selection for CRT? (2017) (0)
Left ventricular wall thickness measured with computed tomography predicts clinical outcomes in patients receiving cardiac resynchronization therapy (2020) (0)
Validation of the VT‐LVAD score for prediction of late VAs in LVAD recipients (2020) (0)
[Heart, vessels and age, main theme of the XXIIIrd European days of the French Society of Cardiology]. (2013) (0)
COllaboration is a Valuable International/Interdisciplinary Directive for Electrophysiology Progress: NOvel & Tangible Important Lessons Learned COVID-EP: NOT ILL Digital health lessons learned from the COVID experience can improve arrhythmic outcomes (2020) (0)
Importance relative de la sequence d'activation ventriculaire et du synchronisme auriculoventriculaire en stimulation cardiaque definitive (1991) (0)
4915Myocardial constructive work is additive to volumetric response to cardiac resynchronization therapy in the prediction of mortality after CRT implantation (2018) (0)
Analysis of longitudinal strain integrals during rest and effort on heart failure patients (2013) (0)
0432: Impact of early complications on outcomes among patients with implantable cardioverter defibrillator in primary prevention (2015) (0)
ANDROGEN‐DEPRIVATION THERAPY AND CARDIOVASCULAR RISK (ADTCR): A NATIONWIDE POPULATION‐BASED COHORT STUDY: MP57‐11 (2017) (0)
Relationship between Holter findings immediately after ablation of typical atrial flutter and subsequent risk of atrial fibrillation. (2012) (0)
[Coronary steal syndrome by systemic pulmonary hypervascularization fed by a mammary-left anterior descending artery bypass. Treatment by embolization]. (2001) (0)
Abstract 4854: Cardiac Resynchronisation Therapy in Elderly Patients: Effects on Quality of Life. A Secondary Analysis from CARE-HF (2008) (0)
16-51: Evolution of ICD lead parameters after continuous-flow LVAD implantation (2016) (0)
557 Echocardiographic assessments of left atrial function and filling pressure correlate with exercise capacity in patients with chronic congestive heart failure (2007) (0)
[The future of cardiology]. (2014) (0)
Comparison of Outcomes and Mortality in Patients Having Left Ventricular Assist Device Implanted Early -vs- Late After Diagnosis of Cardiomyopathy. (2021) (0)
Abstract 2937: Unexpectedly Low Incidence of Atrial Fibrillation in Heart Failure Patients Treated by Cardiac Resynchronization Therapy (2006) (0)
Clinical Predictors of QRS Duration in Patients with LBBB: Data from the AdaptResponse Trial (2019) (0)
Success and complication rate of Tightrail mechanical percutaneous lead extraction: a multicenter French study (2020) (0)
[MUSTIC trial]. (2002) (0)
Clinical predictors of challenging atrioventricular node ablation for rate control in patients with atrial fibrillation (2017) (0)
Comparison of left ventricular remodeling and cardiac work evolution at 6 month between percutaneous mitral valve repair and optimal medical treatment in secondary mitral regurgitation (2019) (0)
From innovation to guideline implementation: a long way (2019) (0)
0230 : Effectiveness of extracorporeal life support for patients with cardiogenic shock due to intractable arrhythmic storm (2015) (0)
P6470Myocardial constructive work is a predictor of long-term outcomes in patients with heart failure undergoing cardiac resynchronization therapy (2018) (0)
Predictive value of QRS changes after cardiac resynchronization therapy. (2012) (0)
[Permanent cardiac pacing in 1993: its objectives, means and results]. (1994) (0)
[Cardiac insufficiency: prevention of ventricular arrhythmias]. (2000) (0)
Poster session IV * Friday 10 December 2010, 14:00-18:00 (2010) (0)
0388: Natural history of primary prevention implantable cardioverter defibrillators: results of a French multi-centric registry (2015) (0)
109-01: Left Ventricular Endocardial Pacing for Non-Responders to CRT, a Subgroup Analysis of the ALSYNC Study (2016) (0)
Abstract 5891: Incidence and Prognostic impact of Spontaneous Conversion to Sinus Rhythm in Patients with Permanent Atrial Fibrillation treated with Cardiac Resynchronization Devices (2008) (0)
Impact of mitral regurgitation correction (Mitraclip® vs. surgical repair) on left ventricular myocardial performance according to baseline LVEF (2018) (0)
Performance-based risk-sharing arrangements for devices and procedures in cardiac electrophysiology: an innovative perspective. (2022) (0)
059: Clinical evidence of LBBB-induced cardiomyopathy: reversal by cardiac resynchronisation (2013) (0)
Predicting left ventricular reverse remodeling as well as outcome after cardiac resynchronization therapy with a score combining clinical, electrocardiographic, and echocardiographic parameters (2015) (0)
[Results of coronary-angiographic evaluation after endocavitary fulguration of the accessory pathways]. (1992) (0)
424 Left ventricular function after correction of a proportionate mitral regurgitation: impact of the clipping approach (2020) (0)
P2404Percutaneous mitral valve repair in secondary mitral regurgitation improves cardiac work (2017) (0)
Cardiac resynchronization: what's next? (2012) (0)
Poster session I * Thursday 9 December 2010, 08:30-12:30 (2010) (0)
Abstract 3381: Further Reverse Ventricular Remodeling by Dual-site Left Ventricular Pacing in Cardiac Resynchronization Therapy (2006) (0)
Abstract 826: Cardiac Resynchronisation Therapy in Elderly Patients: Effects on Left Ventricular Remodeling. A Secondary Analysis from CARE-HF (2008) (0)
223Early post-operative ventricular arrhythmias increase mortality in patient with continuous-flow left ventricular assist device (2018) (0)
176-66: Influence of scar presence and distribution on long-term reverse remodeling by cardiac resynchronization therapy with MultiPoint Pacing (2016) (0)
Abstract 2909: Determinants of Mitral Regurgitation Severity in Chronic Systolic Heart Failure. A Longitudinal and Radial Strain and Strain Rate Echocardiographic Study in 90 Consecutive Patients (2006) (0)
Coronary Subclavian Steal Syndrome After Left Internal Mammary Bypass in Patient with Takayasu's Disease Treated by Endarterectomy (2001) (0)
539 Optimized multiparametric analysis of cardiac dyssynchrony: machine learning and prediction of response to cardiac resynchronization therapy based of the apical 4-chamber view (2020) (0)
P3540Prognostic role of exercise tricuspid annular plane systolic excursion in pauci-symptomatic patients with severe primary mitral regurgitation (2017) (0)
P2408Impact of mitral regurgitation correction (mitraclip vs surgical repair) on left ventricular myocardial performance according to baseline left ventricular ejection fraction (2017) (0)
Acute Improvement of Mechanical Dyssynchrony and Contractility With Multisite LV Pacing Delivered Via a Novel Quadripolar Pacing System (2012) (0)
EHRA Congress 2018. (2018) (0)
176-10: Localization and Ablation of Conduction Gaps after Wide Antral Circumferential Ablation of Atrial Fibrillation (2016) (0)
P2783 Cardiac resynchronization therapy in patients with advanced heart failure: long-term results of a prospective single-centre study (2003) (0)
[Cardiac resynchronization therapy: today's and tomorrow's indications]. (2007) (0)
Original InvestigationWITHDRAWAL: Prediction of Nonarrhythmic Mortality in Primary Prevention Implantable Cardioverter-Defibrillator Patients With Ischemic and Nonischemic Cardiomyopathy (2015) (0)
073 - Very long-term effects of pacing therapy in Hypertrophic Obstructive Cardiomyopathy (HOCM) (2013) (0)
PHP36 PATIENT TRANSFER DECREASE AND HEALTH INSURANCE COSTS SAVINGS ASSOCIATED WITH TELEMEDICINE CONSULTATION. EXAMPLE OF THE TELEMEDICINE NETWORK OF “MIDI-PYRéNéES” (RTR) (2007) (0)
A single-center experience in transvenous coronary sinus lead extraction and re-implantation. Technical issues and alternative re-implantation approaches (2013) (0)
[Cardiac resynchronization: past, present and future]. (2012) (0)
Outcomes of Left Ventricular Assist Device Implantation in Patients With Uncommon Etiology Cardiomyopathy. (2020) (0)
Abstracts: Pacing indications and outcome (2009) (0)
The European Society of Cardiology Cardiac Resynchronization Therapy Survey II: A comparison of cardiac resynchronization therapy implantation practice in Europe and France. (2019) (0)
CARDIAC RESYNCHRONIZATION THERAPY here Is Plenty of Room for ardiac Resynchronization Therapy evices Without Back-Up Defibrillators n the Electrical Treatment of Heart Failure (2005) (0)
Young Investigator Award Session: Clinical Science. (2016) (0)
Clinical Role Echocardiographic Evaluation and Its : A Review of Its * Blind-Ended Structure The Left Atrial Appendage , a Small (2010) (0)
Unexpectedly low incidence of atrial fibrillation in heart failure patients treated by cardiac resynchronization therapy (2006) (0)
JESFC 2023: The return to the great celebration of the French-speaking cardiology community (2023) (0)
[Pacing and heart failure]. (1998) (0)
Poster Session 2: Primary prevention (2009) (0)
3876Cardioverter-defibrillators in hypertrophic cardiomyopathy: a French multicenter study (2017) (0)
Prognostic value of diastolic function assessment in patients undergoing cardiac resynchronization therapy (2021) (0)
18 – Cardiac Resynchronization Therapy (2017) (0)
Optimisation of treatments for heart failure with reduced ejection fraction in routine practice: a position statement from a panel of experts. (2023) (0)
45 Assessment of left ventricular dyssynchrony and prediction of response to cardiac resynchronization therapy: a new three-dimensionnal echocardiography integral-based indicator of longitudinal strain (2015) (0)
Electrical therapies for heart failure (2017) (0)
057 Interventions primaires dune rgion et analyse cartographique (2004) (0)
P3804Left ventricular wall thickness measured with computed tomography predicts mitral regurgitation improvement in patients implanted with cardiac resynchronization therapy (2019) (0)
A stepwise strategy using TightRailTM rotating mechanical dilator sheath is safe and effective for transvenous lead extraction (2018) (0)
Ablation of multifocal premature ventricular contractions using automated pace-mapping software. (2022) (0)
B-PO04-040 LEAD FIXATION MECHANISM AFFECTS TRANSVENOUS LEAD EXTRACTION DIFFICULTY BUT NOT CLINICAL SUCCESS: DATA FROM THE EUROPEAN LEAD EXTRACTION CONTROLLED REGISTRY (ELECTRA) (2021) (0)
Cardiovascular disease in the COVID-19 pandemic: risk and risk reduction (2020) (0)
201 Review of 49 cases of transvenous pacemaker or defibrillator lead extraction in cardiac device-related infective endocarditis context: analysis of safety and efficiency (2010) (0)
Septal versus apical pacing sites in permanent right ventricular pacing: The multicentre prospective SEPTAL-PM study. (2022) (0)
Associations Between Plasma Natriuretic Peptide Levels, Symptoms, and Left Ventricular Function in Patients With Chronic Aortic Regurgitation (2003) (0)
178: Reverse electrical remodeling by cardiac resynchronization therapy: prevalence and clinical impact (2013) (0)
325 Clinical presentation and long-term clinical outcomes of non immune, isolated atrioventricular block diagnosed in utero or early childhood (2012) (0)
Surface electrocardiogram ventricular arrhythmia synthesis from intracardiac signals: an animal study (2011) (0)
[Electrical treatment in heart failure]. (2010) (0)
P1235A stepwise strategy using TightRailTM Rotating Mechanical Dilator Sheath is safe and effective for transvenous lead extraction (2018) (0)
Abstract 17137: Natural History of the Primary Prevention Implantable Cardioverter Defibrillator Therapy in France (2002-2012) (2014) (0)
Not too late, not too fast!! (2009) (0)
Determinants of left atrial volume index in patients with aortic stenosis. A multicentre pilot study (2017) (0)
96Cost effectiveness of a risk-stratified approach to cardiac resynchronisation therapy defibrillators at the time of generator change (2017) (0)
Dynamic changes in nocturnal heart rate predict short-term cardiovascular events in patients using the wearable cardioverter-defibrillator: from the WEARIT-France cohort study. (2023) (0)
The unexpected incidence of complete atrio-ventricular block in CRT-implanted patients (2013) (0)
Left ventricular myocardial performance and atrioventricular coupling in patients with primary arterial hypertension (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Christopher Leclercq?

Christopher Leclercq is affiliated with the following schools: